Home/Filings/4/0001127602-24-006388
4//SEC Filing

Birkett Bernard 4

Accession 0001127602-24-006388

CIK 0000105770other

Filed

Feb 21, 7:00 PM ET

Accepted

Feb 22, 6:13 PM ET

Size

6.8 KB

Accession

0001127602-24-006388

Insider Transaction Report

Form 4
Period: 2024-02-20
Birkett Bernard
Sr VP, Chief Financial Officer
Transactions
  • Award

    Common Stock

    2024-02-20+1,9696,889.42 total
  • Award

    Stock Options (Right to Buy)

    2024-02-20+8,3468,346 total
    Exercise: $350.18From: 2025-02-20Exp: 2034-02-20Stock Options (Right to Buy) (8,346 underlying)
Footnotes (2)
  • [F1]2021 PSUs (PP20) award vesting net of taxes withheld.
  • [F2]This grant vests in four equal installments beginning on February 20, 2025.

Issuer

WEST PHARMACEUTICAL SERVICES INC

CIK 0000105770

Entity typeother

Related Parties

1
  • filerCIK 0001658001

Filing Metadata

Form type
4
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 6:13 PM ET
Size
6.8 KB